North America Biobanks Market Growth, Trends and Forecasts 2017 - 2022

  • ID: 4387299
  • Report
  • Region: America, North America, United States
  • 121 pages
  • Mordor Intelligence
1 of 3
The North American biobanks market was valued at USD 72.47 million in 2014 and is expected to become a USD 97.22 million market by 2019. During this period, the market is expected to show a CAGR of 6.05%

North America Biobanks Market- Market Dynamics

The report studies the many factors driving and restraining the market. Some of these are discussed below.

Drivers

The factors propelling the biobank market are the high incidence of disease and the recent advances in the tools and technology of molecular biology and genetics leading to increased demand for well-annotated, properly preserved specimens. Also contributing to the growth of this market are issues such as major financial and scientific investments by millions of citizens who have voluntarily contributed data and bio-specimens to such biobanks. These investments have permitted major progress in the comprehension of specific risk factors for complex diseases. Contributing to these drivers are other factors such as the poor productivity of the pharmaceutical industry with respect to the new drug approvals. The drive to contain ever-increasing healthcare costs is driving an unprecedented interest in biomarkers.

Restraints

Privacy and confidentiality issues are holding back the growth of the market. Access policies and procedures are also challenging the growth of this market. On top of this, there are a lot of regulation-based issues with the biobanking procedure that are hindering the growth of this market. Privacy and surveillance issues, fears of privatization and lack of governance are also key restraints to this market.

From the geographical point of view, the US has the largest market share. While nearly two-thirds of biobanks were established within the last decade, 17% have been in existence for over 20 years. 53% listed research on a particular disease as the most important reason for establishment; 29% listed research generally. 44% of biobanks store pediatric specimens, and 36% include postmortem specimens. Most biobanks are affiliated in one or multiple ways with other entities: 88% are part of at least one or more larger organizations (67% of these are academic, 23% hospitals, 13% research institutes). The majority of biobanks seem to fill a particular niche within a larger organization or research area; a minority is concerned about competition for services but many are worried about underutilization of specimens and long-term funding.

North Americabiobanks market is segmented on the basis of the type of mechanism, equipment used, application in different sectors and geography.

This Report Offers:

Market definition for North AmericaBiobanks market along with identification of key drivers and restraints for the market.

Market analysis for the North America Biobanks market, with region-specific assessments and competition analysis on a North America and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a North America and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their share of markets.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

An exhaustive understanding of the North America Biobanks market.

A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.

An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities, offered.

Wide-ranging information provided about the leading market players and the major strategies adopted by them.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Definition
3.1.1 Introduction
3.2 Market Drivers
3.2.1 Investment by Government & Non-Governmental Organizations
3.2.2 Rise in Chronic Diseases
3.2.3 Advances in Regenerative Medicine
3.2.4 Advances in Drug Discovery & Development
3.3 Market Restraints
3.3.1 Regulatory Issues
3.3.2 Storage Problems
3.3.3 High-Cost techniques
4. NORTH AMERICA MARKETS: SEGMENTATION BY TYPE
4.1 Optimized Pre-Formulated Media
4.2 Non-Optimized Isotonic Formulated Media
5. NORTH AMERICA MARKETS: SEGMENTATION BY EQUIPMENT
5.1 Refrigerators
5.2 Ice Machines
5.3 Freezers
5.4 Cryogenic Storage Systems
5.5 Alarm Monitoring Systems
5.6 LN2 Supply Tanks
6. NORTH AMERICA MARKETS: SEGMENTATION BY APPLICATION
6.1 Drug Discovery
6.2 Biobanking Procedures
6.3 Regenerative Medicine
7. NORTH AMERICA MARKETS: SEGMENTATION BY GEOGRAPHY
7.1 USA
7.2 Canada
7.3 Mexico
8. COMPETITIVE LANDSCAPE
8.1 Introduction
8.2 Mergers & Acquisitions
8.3 Expansions
8.4 New Product Launch
8.5 Collaborations
9. COMPANY PROFILES
9.1 Atlanta Biologicals
9.2 Biolife Solutions
9.3 Bioniche Pharma USA LLC
9.4 Cell & Tissue Systems LLC
9.5 Essential Pharmaceuticals
9.6 Lifeline Scientific Inc.
9.7 Genzyme Corporation
9.8 Sigma Aldrich Corporation
10. Appendix
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll